
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
This 3rd edition has been broadened in its name and scope with the addition of cellular products. Other key revisions include revised requirements for consistency with FDAs proposed good tissue practice regulations, new requirements for interface between collecting and administering facilities, revised donor qualification requirements, new processing tests and new record retention timeframes consistent with proposed GTP requirements.
This 3rd edition establishes updated standards for hematopoietic progenitor cell and cellular product services. The American Association of Blood Banks, in collaboration with S. Karger AG, presents revised requirements to align with evolving regulatory landscapes and clinical practices. Key revisions address consistency with FDA's proposed good tissue practice regulations, the interface between collecting and administering facilities, donor qualification, processing tests, and record retention timeframes.
This publication serves as a critical update for professionals in blood banking and cellular therapy, reflecting advancements and regulatory changes in the field. The revisions indicate a focus on ensuring safety, efficacy, and consistency in the collection, processing, and administration of cellular products. The inclusion of proposed Good Tissue Practice (GTP) regulations suggests an emphasis on compliance and quality management systems within these services. The broadened scope to include cellular products signifies the evolving nature of therapeutic applications derived from blood and tissue.
Page Count:
92
Publication Date:
2002-01-01
Publisher:
American Association of Blood Banks
ISBN-10:
380557567X
ISBN-13:
9783805575676
No comments yet. Be the first to share your thoughts!